Torii Pharmaceutical
Japan - TokyoPharmaceutical
Focus: Torii Pharmaceutical is a Japan-based small molecule specialist with a focused pipeline in dermatology and related therapeutic areas. The company operates at mid-cap biotech scale with limited public disclosure on employee count and financials.
Profile data last refreshed 2h ago · AI intelligence enriched 1w ago
Open Jobs
1+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Torii Pharmaceutical?
AI assessmentTorii is a niche, Japan-headquartered dermatology player with a promising late-stage asset but minimal hiring signals and opaque corporate footprint—suitable only for candidates seeking stability or geographic preference over rapid career trajectory.
Why Work Here
- VP-102 in Phase 3 for common warts represents a late-stage, potentially near-term revenue catalyst with 2 active trials
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
VP-102
Common WartsOpen Jobs (1)
Help build intelligence for Torii Pharmaceutical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.